$97.460
-2.242 (-2.30%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
MIRM Prediction & Forecast by Similar Chart Analysis
Alphio's MIRM stock price prediction model matches the current Mirum Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $97.27 (-0.19%). The 1-week path is $98.79 (+1.36%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Mirum Pharmaceuticals Inc Stock?
Mirum Pharmaceuticals is currently a hold. The stock's current price is $97.46, and while it has shown a year-to-date increase of 24.84%, the RSI is at 40.814, indicating potential weakness. The forward P/E ratio is at 39.68, suggesting it may be overvalued given the recent earnings miss and regulatory hurdles. The main risk is the FDA's requirement for an additional Phase 3 study, which may delay the drug's market entry, creating uncertainty.
MIRM stock price ended at $97.46 on Friday, after losing -2.30%
Mirum Pharmaceuticals Inc (MIRM) last closed at $97.46, losing -2.30%. These facts feed the 1-day and 1-week MIRM price prediction above.
Forecast Drivers
Mirum Pharmaceuticals Inc (MIRM) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches MIRM, ranked by similarity.
Seasonality analysis for MIRM
Historically the probability of a positive August return for MIRM is 100.00%. July offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for MIRM
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $54.81 | $55.69 | $60.19 | -42.85% |
| Sep 2026 | $47.24 | $55.69 | $69.52 | -42.85% |
| Oct 2026 | $72.83 | $75.40 | $83.11 | -22.64% |
| Nov 2026 | $57.34 | $78.46 | $84.24 | -19.50% |
| Dec 2026 | $64.06 | $67.53 | $74.76 | -30.71% |
In 2026, Mirum Pharmaceuticals Inc (MIRM) is projected to range from $47.24 to $84.24.
Mirum Pharmaceuticals Inc 2026 monthly forecast
In Aug 2026, Mirum Pharmaceuticals Inc is projected to average $55.69, with a low of $54.81 and high of $60.19.
In Sep 2026, Mirum Pharmaceuticals Inc is projected to average $55.69, with a low of $47.24 and high of $69.52.
In Oct 2026, Mirum Pharmaceuticals Inc is projected to average $75.40, with a low of $72.83 and high of $83.11.
In Nov 2026, Mirum Pharmaceuticals Inc is projected to average $78.46, with a low of $57.34 and high of $84.24.
In Dec 2026, Mirum Pharmaceuticals Inc is projected to average $67.53, with a low of $64.06 and high of $74.76.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.